Skip to content

Clinical trials

Phase 2 Uterine Cervical Neoplasms trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Uterine Cervical Neoplasms Phase: Phase 2 Country / region: South Korea Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20071
20081
20091
20111
20181
20191
20202
20214
20243
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting6
Terminated2
Active, not recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche2
Korea Cancer Center Hospital2
Korean Gynecologic Oncology Group2
Agenus Inc.1
AstraZeneca1
Bayer1
BeiGene1
Daiichi Sankyo1
EMD Serono Research & Development Institute, Inc.1
Inovio Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Uterine Cervical Neoplasms20
Endometrial Neoplasms4
Ovarian Neoplasms4
Breast Neoplasms3
Esophageal Neoplasms3
Stomach Neoplasms3
Urinary Bladder Neoplasms3
Biliary Tract Neoplasms2
Carcinoma, Non-Small-Cell Lung2
Colorectal Neoplasms2

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.